224 results on '"Yamagami J"'
Search Results
2. 064 Early Clinical Score Changes Predict Additional Treatment Necessity In Pemphigus/Pemphigoid
3. Evaluation of pharyngo‐oesophageal involvement in pemphigus vulgaris and its correlation with disease activity
4. Analysis of clinical characteristics, prognosis and antibody pathogenicity of pemphigus patients positive for anti‐desmoglein IgG autoantibodies in remission: a retrospective cohort study
5. Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages
6. Optic Disc Findings and Disc Hemorrhages in Low-Tension Glaucoma and Their Therapeutical Suggestion
7. Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell–mediated inflammation in the skin
8. 037 Efficacy and safety of tirabrutinib, highly selective Bruton’s tyrosine kinase inhibitor, for oral treatment of pemphigus: a multicenter, open-label, uncontrolled, single-arm phase 2 study
9. Alopecia as a rare but distinct manifestation of pemphigus vulgaris
10. Analysis of clinical characteristics, prognosis and antibody pathogenicity of pemphigus patients positive for anti‐desmoglein IgG autoantibodies in remission: a retrospective cohort study.
11. 013 Fcγ receptor IIb-dependent blockade of immunoglobulin class-switch is crucial to prevent pemphigus onset in desmoglein 3-sepecific B cell receptor knock-in mouse
12. How certain molecules of the immune system affect bullous pemphigoid
13. 免疫系统的某些分子如何影响大疱性类天疱疮
14. A milestone in reaching the goal of complete remission off‐therapy in pemphigus
15. An adult case of X‐linked chronic granulomatous disease with skin ulcer on the nose and internal canthus
16. Results of the guideline‐based treatment for pemphigus: a single‐centre experience with 84 cases
17. Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission
18. The first case of cutaneous mucormycosis caused by Rhizopus azygosporus
19. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results
20. Inter‐rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients
21. Prediction of relapse in the treatment of pemphigus
22. 421 Pemphigus vulgaris IgG autoantibodies directly inhibit heterophilic desmoglein 3-desmocollin 3 adhesion by steric hindrance
23. Reorganization of serum analysis tools for the diagnosis of bullous pemphigoid
24. A two‐step immunoblot assay for serological diagnosis of anti‐laminin γ‐1 pemphigoid
25. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.
26. Autoantibodies undetectable by chemiluminescent enzyme immunoassay require extended antigen–antibody reaction time for detection
27. Azathioprine-induced alopecia and leukopenia associated with NUDT15 polymorphisms
28. The International Bullous Diseases Group consensus on diagnostic criteria for epidermolysis bullosa acquisita: a useful tool for dermatologists
29. 059 Reliability of the BIOCHIP in pemphigus and pemphigoid patients the evaluations of blistering disease experts
30. 017 FcγRIIb deficiency accelerates immunoglobulin class switch and pemphigus phenotype development in pathogenic anti-desmoglein 3 antibody knock-in mice
31. Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors
32. 053 Autoantibodies in vancomycin-induced linear IgA bullous dermatosis target type VII collagen in the presence of vancomycin
33. 010 FcgRIIb is important for clonal ignorance and prevents pemphigus phenotype in pathogenic anti-desmoglein 3 antibody knock-in mice
34. Evaluation of pharyngo‐oesophageal involvement in pemphigus vulgaris and its correlation with disease activity
35. 264 Patients with pemphigus foliaceus may retain antibody reactivity against calcium dependent epitopes of desmoglein 1 in remission
36. Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages
37. Detection of Autoantibodies to Precursor Proteins of Desmogleins in Sera of a Patient with Bowen Carcinoma
38. Alopecia as a rare but distinct manifestation of pemphigus vulgaris
39. Treadmill gait analysis 1: Extraction of gait pattern components from Lissajous figure by FFT smoother
40. Autoantibodies undetectable by chemiluminescent enzyme immunoassay require extended antigen–antibody reaction time for detection.
41. Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0.12% unoprostone
42. Trabeculectomy with mitomycin C for post-keratoplasty glaucoma
43. [Combined posterior chamber intraocular lens implantation and trabeculectomy--a life-table analysis of postoperative clinical course]
44. EFFECTS OF I.P.P.B. THERAPY ON SILICOTIC PATIENTS
45. Cases of Subacute Silicosis found in a Clay Refinery
46. Changes of Cardiopulmonary Function under Seasonal Influence among the Hospitalized Pneumoconiotic Patients
47. Quantitative assessment of tumour extraction from dermoscopy images and evaluation of computer-based extraction methods for an automatic melanoma diagnostic system
48. Long-term movements of an earthflow in tectonised clay shales
49. Development of a novel treatment for pemphigus and confirmation of its efficacy: a randomized controlled trial of protein A immunoadsorption therapy.
50. A case of IgA pemphigus with acantholysis in oral mucosal lesions.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.